Sort
82,697 grants matching “vaccine development”
Institute for Clinical and Translational Research
$1,219,191Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2017 · TR
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY
$1,219,119University Of Washington · U24 · FY2005 · RR
Pediatric Clinical Trials Program for AIDS
$1,219,019Baylor College Of Medicine · U01 · FY2002 · AI
Specific Pathogen Free Baboon Research Resource (SPFBRR)
$1,218,926Joe H. Simmons · University Of Tx Md Anderson Can Ctr · P40 · FY2021 · OD
Innate inflammatory responses during pulmonary infections
$1,218,475Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Immunity to Pneumonic Tularemia
$1,217,958Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Production Development
$1,217,859Niranjan Y Sardesai · Wistar Institute · U19 · FY2016 · AI
Task 02: Manufacture of Influenza for Human Challenge Clinical Trials
$1,217,730Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2019 · AI
Non-Human Primate Core
$1,217,631Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIC · FY2017 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,217,443Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
PROJECT 1: Design of native-like SOSIP trimers
$1,217,315John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
PROJECT 2:Structural studies of SOSIP trimers
$1,217,315Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
NIAID/MRMC Comprehensive HIV/AIDS Therapeutic and Non-Vaccine Prev Clin, Research
$1,217,148National Institute Of Allergy And Infectious Diseases · Y01 · FY2010 · AI
Virome and Immune Responses associated with IA and Type 1 Diabetes
$1,216,506Richard E Lloyd · Baylor College Of Medicine · R01 · FY2025 · DK
NATURAL HISTORY OF AIDS IN HOMOSEXUAL MEN
$1,216,301University Of California Los Angeles · U01 · FY2004 · AI
Adjuvant Development in the context of vaccines for Zika, Dengue and West Nile virus
$1,216,047Sunil David · Virovax Llc · N01 · FY2019 · AI
Modulation of Biodefense Responses to Bacterial Pathogen
$1,215,884Leo Lefrancois · University Of Connecticut Sch Of Med/Dnt · P01 · FY2007 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$1,215,815Pablo Tebas · University Of Pennsylvania · UM1 · FY2017 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$1,215,815Pablo Tebas · University Of Pennsylvania · UM1 · FY2018 · AI
Modulation of Biodefense Responses to Bacterial Pathogen
$1,215,725Leo Lefrancois · University Of Connecticut Sch Of Med/Dnt · P01 · FY2006 · AI
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$1,215,618Kenner Rice · National Institute On Drug Abuse · ZIA · FY2023 · DA
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,215,514Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Center for Computational Mass Spectrometry
$1,215,402Pavel A Pevzner · University Of California, San Diego · P41 · FY2017 · GM
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$1,215,107Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV
$1,214,934Roger L Shapiro · Harvard School Of Public Health · P01 · FY2022 · HD